Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
AGL agilon health inc
- Stocks
- Healthcare
- NYSE: AGL
Price (delayed)
$2.7
Market cap
$1.12B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.58
Enterprise value
$1.01B
agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians
Highlights
The company's revenue rose by 23% YoY
The EPS is up by 16% year-on-year and by 8% since the previous quarter
The equity has decreased by 27% YoY but it has increased by 6% QoQ
The company's gross profit has shrunk by 127% YoY
The gross margin has dropped by 120% year-on-year
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.agilonhealth.com
Peers:
TOI
Key stats
What are the main financial stats of AGL
Market
Valuations
Earnings
Shares outstanding
413.95M
Market cap
$1.12B
Enterprise value
$1.01B
Price to earnings (P/E)
N/A
Price to book (P/B)
2.23
Price to sales (P/S)
0.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.17
Revenue
$5.99B
Gross profit
-$19.53M
Operating income
-$307.06M
Net income
-$241.98M
EBIT
-$233.79M
EBITDA
-$208.29M
Free cash flow
-$55.95M
Per share
Balance sheet
Liquidity
EPS
-$0.58
EPS diluted
-$0.58
Free cash flow per share
-$0.14
Book value per share
$1.21
Revenue per share
$14.5
TBVPS
$4.46
Total assets
$1.93B
Total liabilities
$1.43B
Debt
$34.92M
Equity
$500.25M
Working capital
$276.02M
Debt to equity
0.07
Current ratio
1.2
Quick ratio
1.17
Net debt/EBITDA
0.5
Margins
Efficiency
Dividend
EBITDA margin
-3.5%
Gross margin
-0.3%
Net margin
-4%
Operating margin
-5.1%
Return on assets
-12.2%
Return on equity
-43.5%
Return on invested capital
-53.4%
Return on capital employed
-41.9%
Return on sales
-3.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AGL stock price
How has the agilon health stock price performed over time
Intraday
-9.09%
1 week
-39.46%
1 month
-52.46%
1 year
-48.18%
YTD
42.11%
QTD
-37.64%
Financial performance
How have agilon health's revenue and profit performed over time
Revenue
$5.99B
Gross profit
-$19.53M
Operating income
-$307.06M
Net income
-$241.98M
Gross margin
-0.3%
Net margin
-4%
The company's gross profit has shrunk by 127% YoY
The gross margin has dropped by 120% year-on-year
The net margin has grown by 31% YoY and by 7% from the previous quarter
The operating income has contracted by 28% YoY and by 5% from the previous quarter
Price vs fundamentals
How does AGL's price correlate with its fundamentals
Growth
What is agilon health's growth rate over time
Valuation
What is agilon health stock price valuation
P/E
N/A
P/B
2.23
P/S
0.19
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.17
The EPS is up by 16% year-on-year and by 8% since the previous quarter
The stock's P/B is 69% less than its 5-year quarterly average of 7.1 and 26% less than its last 4 quarters average of 3.0
The equity has decreased by 27% YoY but it has increased by 6% QoQ
AGL's P/S is 94% below its 5-year quarterly average of 3.2 and 37% below its last 4 quarters average of 0.3
The company's revenue rose by 23% YoY
Efficiency
How efficient is agilon health business performance
The return on sales is up by 32% year-on-year and by 7% since the previous quarter
AGL's return on invested capital is down by 24% year-on-year and by 6% since the previous quarter
The ROE fell by 19% YoY
The ROA is up by 7% year-on-year and by 2.4% since the previous quarter
Dividends
What is AGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AGL.
Financial health
How did agilon health financials performed over time
agilon health's total assets is 35% more than its total liabilities
agilon health's total assets has decreased by 17% YoY but it has increased by 11% from the previous quarter
agilon health's total liabilities has increased by 13% QoQ but it has decreased by 12% YoY
The debt is 93% less than the equity
The company's debt to equity rose by 40% YoY
The equity has decreased by 27% YoY but it has increased by 6% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.